Delivery Order SPE2DB25D3404-SPE2DB25FUNYT

Award Date 6/23/25
Potential Completion Date 6/24/25
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical product, with a ceiling value of $1,726.60. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $1,153.40 and an ultimate completion date of April 23, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,589.87 and a performance period ending on May 13, 2025. The contract is not set aside for any particular business category. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The contract has a ceiling value of $1,043.39 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of...
This contract award, with a ceiling value of $12,730.51, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medical product "TYPHIM VI 25 MCG/0.5 ML VIAL 10ML" and has a period of performance through March 6, 2024. The contract is a firm fixed-price arrangement and was not set aside for any specific business category....
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a total ceiling value of $11,336.56. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. The contract has an ultimate completion date of May 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,653.15 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical product, and has a ceiling value of $17,265.80. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of February 24, 2025. It is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a ceiling value of $3,453.16 and a completion date of June 11, 2025. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor for this...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a delivery order. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a ceiling value of $9,073.58. It is a firm fixed-price delivery order contract with a completion date of June 12, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUNYT
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $5,406.55. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/22/25, 9:55 AM